CysLT(1) leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors

Montelukast and pranlukast are orally active leukotriene receptor antagonists selective for the CysLT(1) receptor. Conversely, the hP2Y(1,2,4,6,11,12,13,14) receptors represent a large family of GPCRs responding to either adenine or uracil nucleotides, or to sugar-nucleotides. Montelukast and pranlu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biochem Pharmacol
Main Authors: Mamedova, Liaman, Capra, Valérie, Accomazzo, Maria Rosa, Gao, Zhan-Guo, Ferrario, Silvia, Fumagalli, Marta, Abbracchio, Maria P., Rovati, G. Enrico, Jacobson, Kenneth A.
Format: Artigo
Jezik:Inglês
Izdano: 2005
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4967539/
https://ncbi.nlm.nih.gov/pubmed/16280122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2005.10.003
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki